Psilocybin for Treatment of Obsessive Compulsive Disorder

Phase: PHASE1, PHASE2 | Sponsor: Francisco A Moreno | Compound: Psilocybin

Status

planned

Institution

Francisco A Moreno

Start date

2026-01-01

End date

2028-12-01

Registry ID

NCT06992999

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.